These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. IMMUNOHISTOCHEMICAL STUDY OF THROMBOLYTIC MECHANISMS. BACK N; HIRAMOTO R; AMBRUS JL Blood; 1965 Jun; 25():1028-36. PubMed ID: 14294764 [No Abstract] [Full Text] [Related]
11. THE STREPTOKINASE ACTIVATION OF HUMAN PLASMINOGEN. DIRECT ANALYSIS OF THE ACTIVATION MIXTURE. RIFE U; SHULMAN S Thromb Diath Haemorrh; 1963 Nov; 10():133-45. PubMed ID: 14081275 [No Abstract] [Full Text] [Related]
12. THROMBOLYTIC THERAPY. DOUGLAS AS; MCNICOL GP Proc R Soc Med; 1964 Jul; 57(7):609-14. PubMed ID: 14178954 [No Abstract] [Full Text] [Related]
13. STUDIES ON THE ACTIVATION OF PLASMINOGEN. II. ON THE NATURE OF THE PROACTIVATOR. GUTMAN M; RIMON A Can J Biochem; 1964 Sep; 42():1339-45. PubMed ID: 14217241 [No Abstract] [Full Text] [Related]
14. [THERAPEUTIC FIBRINOLYSIS. I. STUDIES ON THE EFFECTS OF STREPTOKINASE AND ACTASE IN VITRO]. JUERGENS J Klin Wochenschr; 1964 Jun; 42():534-8. PubMed ID: 14233281 [No Abstract] [Full Text] [Related]
15. THE CASEINOLYTIC METHOD FOR DETERMINATION OF PLASMINOGEN-PLASMIN IN HUMAN PLASMA AND SERUM. JACOBSEN CD Scand J Clin Lab Invest; 1964; 16():372-82. PubMed ID: 14202017 [No Abstract] [Full Text] [Related]
16. CURRENT STATUS OF THROMBOLYTIC THERAPY. SHERRY S Geriatrics; 1964 Sep; 19():628-43. PubMed ID: 14221883 [No Abstract] [Full Text] [Related]
17. USE OF CHROMIUM51-TAGGED CASEIN FOR THE DETERMINATION OF PROTEOLYTIC ACTIVITY. RITZ ND; RUBIN H J Lab Clin Med; 1964 Feb; 63():344-54. PubMed ID: 14125123 [No Abstract] [Full Text] [Related]
18. [THE CURRENT STATUS OF FIBRINOLYTIC THERAPY]. KAPPERT A Med Klin; 1963 Nov; 58():1844-6. PubMed ID: 14100260 [No Abstract] [Full Text] [Related]
19. SOME CONSIDERATIONS IN THE SYSTEMIC USE OF FIBRINOLYTIC AGENT. COON WW Mich Med; 1964 Jul; 63():488-90. PubMed ID: 14182774 [No Abstract] [Full Text] [Related]